Literature DB >> 7811923

Kinetic study of the aggregation and lipid mixing produced by alpha-sarcin on phosphatidylglycerol and phosphatidylserine vesicles: stopped-flow light scattering and fluorescence energy transfer measurements.

J M Mancheño1, M Gasset, J Lacadena, F Ramón, A Martínez del Pozo, M Oñaderra, J G Gavilanes.   

Abstract

alpha-Sarcin is a fungal cytotoxic protein that inactivates the eukaryotic ribosomes. A kinetic study of the aggregation and lipid mixing promoted by this protein on phosphatidylglycerol (PG) and phosphatidylserine (PS) vesicles has been performed. Egg yolk PG, bovine brain PS, dimyristoyl-PG (DMPG) and dimyristoyl-PS (DMPS) vesicles have been considered. The initial rates of the vesicle aggregation induced by the protein have been measured by stopped-flow 90 degrees light scattering. The formation of a vesicle dimer as the initial step of this process was deduced from the second-order dependence of the initial rates on phospholipid concentration. The highest alpha-sarcin concentration studied did not inhibit the vesicle aggregation, indicating that many protein molecules are involved in the vesicle cross-linking. These are common characteristics of the initial steps of the aggregation produced by alpha-sarcin in the four types of phospholipid vesicles considered. However, the kinetics of the scattering values revealed that more complex changes occurred in the later steps of the aggregation process of egg PG and brain PS vesicles than in those of their synthetic counterparts. alpha-Sarcin produced lipid mixing in vesicles composed of DMPG or DMPS, which was measured by fluorescence resonance energy transfer assays. A delay in the onset of the process, dependent on the protein concentration, was observed. Measurement of the rates of lipid mixing revealed that the process is first order on phospholipid concentration. Egg PG and brain PS vesicles did not show lipid mixing, although they avidly aggregated. However, alpha-sarcin was able to promote lipid mixing in heterogeneous systems composed of egg PG+DMPG or brain PS+DMPS vesicles. The dilution of the fluorescence probes was faster when these were incorporated into the bilayers made of synthetic phospholipids than were present in those made of natural phospholipids. The bilayer destabilization produced by the protein in the vesices composed of the dimyristoyl-phospholipids should be transmitted to the more stable ones made of natural phospholipids. The obtained results are interpreted in terms of lipid mixing occurring within vesicle aggregates larger than dimer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811923      PMCID: PMC1225465          DOI: 10.1016/S0006-3495(94)80578-8

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  17 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Viral infection permeabilizes mammalian cells to protein toxins.

Authors:  C Fernández-Puentes; L Carrasco
Journal:  Cell       Date:  1980-07       Impact factor: 41.582

3.  The rate of fusion of phospholipid vesicles and the role of bilayer curvature.

Authors:  S Nir; J Wilschut; J Bentz
Journal:  Biochim Biophys Acta       Date:  1982-05-21

4.  Study of the interaction between the antitumour protein alpha-sarcin and phospholipid vesicles.

Authors:  M Gasset; A Martinez del Pozo; M Oñaderra; J G Gavilanes
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

5.  Monolayer characteristics and thermal behavior of natural and synthetic phosphatidylserines.

Authors:  R A Demel; F Paltauf; H Hauser
Journal:  Biochemistry       Date:  1987-12-29       Impact factor: 3.162

6.  Stopped-flow studies of myelin basic protein association with phospholipid vesicles and subsequent vesicle aggregation.

Authors:  P D Lampe; G J Wei; G L Nelsestuen
Journal:  Biochemistry       Date:  1983-03-29       Impact factor: 3.162

7.  On the nature of calcium ion binding between phosphatidylserine lamellae.

Authors:  G W Feigenson
Journal:  Biochemistry       Date:  1986-09-23       Impact factor: 3.162

8.  Fusion of phospholipid vesicles produced by the anti-tumour protein alpha-sarcin.

Authors:  M Gasset; M Oñaderra; P G Thomas; J G Gavilanes
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

9.  The primary structure of the cytotoxin alpha-sarcin.

Authors:  G Sacco; K Drickamer; I G Wool
Journal:  J Biol Chem       Date:  1983-05-10       Impact factor: 5.157

10.  Fluorescence studies on the lipoprotein complex of the fatty acid synthetase from the insect Ceratitis capitata.

Authors:  J G Gavilanes; M A Lizarbe; A M Municio; M Oñaderra
Journal:  Biochemistry       Date:  1981-09-29       Impact factor: 3.162

View more
  4 in total

1.  Involvement of the amino-terminal beta-hairpin of the Aspergillus ribotoxins on the interaction with membranes and nonspecific ribonuclease activity.

Authors:  L García-Ortega; J Lacadena; J M Mancheño; M Oñaderra; R Kao; J Davies; N Olmo; J G Gavilanes
Journal:  Protein Sci       Date:  2001-08       Impact factor: 6.725

2.  Membrane interaction of a beta-structure-forming synthetic peptide comprising the 116-139th sequence region of the cytotoxic protein alpha-sarcin.

Authors:  J M Mancheño; M Gasset; J P Albar; J Lacadena; A Martínez del Pozo; M Oñaderra; J G Gavilanes
Journal:  Biophys J       Date:  1995-06       Impact factor: 4.033

3.  Substitution of histidine-137 by glutamine abolishes the catalytic activity of the ribosome-inactivating protein alpha-sarcin.

Authors:  J Lacadena; J M Mancheño; A Martinez-Ruiz; A Martínez del Pozo; M Gasset; M Oñaderra; J G Gavilanes
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

Review 4.  Hirsutellin A: A Paradigmatic Example of the Insecticidal Function of Fungal Ribotoxins.

Authors:  Elías Herrero-Galán; Lucía García-Ortega; Miriam Olombrada; Javier Lacadena; Álvaro Martínez Del Pozo; José G Gavilanes; Mercedes Oñaderra
Journal:  Insects       Date:  2013-07-09       Impact factor: 2.769

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.